Biopharmaceutical proteins: opportunities and challenges.
Birch
John R
JR
Lonza Biologics plc, Slough, UK.
Onakunle
Yemi
Y
D000818:Animals; D000906:Antibodies / Q000737:chemistry / Q000276:immunology; D001702:Biopharmaceutics / Q000379:methods / Q000639:trends*; D004345:Drug Industry / Q000379:methods / Q000639:trends; D006031:Glycosylation; D006801:Humans; D011092:Polyethylene Glycols / Q000737:chemistry; D015202:Protein Engineering; D011506:Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use*
D000906:Antibodies; D011506:Proteins; D011092:Polyethylene Glycols